- Labeler Index
- Sanofi-aventis U.s. Llc
- 0024-5903
- NDC Crossover: 0024-5903 Praluent
NDC Crossover 0024-5903 Praluent
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Alirocumab
Explore similar products and medications to NDC 0024-5903 Praluent a human prescription drug with other products crossover matching the same product name (Praluent) or generic name (Alirocumab), and the same administration route (subcutaneous) or dosage form (injection, solution). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0024-5901 | Praluent | Alirocumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0024-5902 | Praluent | Alirocumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0024-5904 | Praluent | Alirocumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
61755-020 | Praluent | Alirocumab | Injection, Solution | Subcutaneous | Regeneron Pharmaceuticals, Inc. | Human Prescription Drug |
61755-021 | Praluent | Alirocumab | Injection, Solution | Subcutaneous | Regeneron Pharmaceuticals, Inc. | Human Prescription Drug |
72733-5901 | Praluent | Alirocumab | Injection, Solution | Subcutaneous | Sanofi Us Corporation | Human Prescription Drug |
72733-5902 | Praluent | Alirocumab | Injection, Solution | Subcutaneous | Sanofi Us Corporation | Human Prescription Drug |